ZA200409095B - Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same. - Google Patents
Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same.Info
- Publication number
- ZA200409095B ZA200409095B ZA200409095A ZA200409095A ZA200409095B ZA 200409095 B ZA200409095 B ZA 200409095B ZA 200409095 A ZA200409095 A ZA 200409095A ZA 200409095 A ZA200409095 A ZA 200409095A ZA 200409095 B ZA200409095 B ZA 200409095B
- Authority
- ZA
- South Africa
- Prior art keywords
- medicament
- production
- same
- diagnostic reagent
- substituted thiophenes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10224892A DE10224892A1 (en) | 2002-06-04 | 2002-06-04 | Substituted thiophenes, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200409095B true ZA200409095B (en) | 2005-05-10 |
Family
ID=29557542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200409095A ZA200409095B (en) | 2002-06-04 | 2004-11-10 | Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same. |
Country Status (33)
| Country | Link |
|---|---|
| EP (1) | EP1513834B1 (en) |
| JP (1) | JP4511924B2 (en) |
| KR (1) | KR101087966B1 (en) |
| CN (1) | CN1324024C (en) |
| AR (1) | AR040239A1 (en) |
| AT (1) | ATE320425T1 (en) |
| AU (1) | AU2003273553B2 (en) |
| BR (1) | BR0311548A (en) |
| CA (1) | CA2488242C (en) |
| CR (1) | CR7577A (en) |
| DE (2) | DE10224892A1 (en) |
| DK (1) | DK1513834T3 (en) |
| EC (1) | ECSP045471A (en) |
| ES (1) | ES2258722T3 (en) |
| HK (1) | HK1076460A1 (en) |
| HR (1) | HRP20041153A2 (en) |
| IL (1) | IL165519A (en) |
| MA (1) | MA27204A1 (en) |
| ME (1) | MEP27608A (en) |
| MX (1) | MXPA04011986A (en) |
| MY (1) | MY129832A (en) |
| NO (1) | NO329351B1 (en) |
| OA (1) | OA12827A (en) |
| PE (1) | PE20040534A1 (en) |
| PL (1) | PL372589A1 (en) |
| PT (1) | PT1513834E (en) |
| RS (1) | RS51141B (en) |
| RU (1) | RU2315766C2 (en) |
| TN (1) | TNSN04240A1 (en) |
| TW (1) | TWI283675B (en) |
| UA (1) | UA77551C2 (en) |
| WO (1) | WO2003101984A1 (en) |
| ZA (1) | ZA200409095B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040242560A1 (en) | 2003-05-22 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Process for synthesizing heterocyclic compounds |
| DE10323701A1 (en) | 2003-05-22 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Process for the synthesis of heterocyclic compounds |
| JP4384635B2 (en) | 2003-06-30 | 2009-12-16 | 住友化学株式会社 | Asymmetric urea compound and method for producing asymmetric compound by asymmetric conjugate addition reaction using the same |
| JP2010507664A (en) * | 2006-10-25 | 2010-03-11 | 武田薬品工業株式会社 | Benzimidazole compounds |
| CA2735842A1 (en) | 2008-09-02 | 2010-03-11 | Sanofi-Aventis | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| CA2780031A1 (en) * | 2009-11-12 | 2011-05-19 | Selvita S.A. | A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| RU2518740C1 (en) * | 2013-03-22 | 2014-06-10 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" | METHOD, INHIBITING Na+/H+-EXCHANGE, AND DIHYDROCHLORIDE OF 2-(3,4-METHYLENEDIOXYPHENYL)-9-MORPHOLINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE |
| CN106536502B (en) | 2014-07-25 | 2019-03-05 | 大正制药株式会社 | The phenyl tetrahydro isoquinoline compound being substituted by heteroaryl |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754935A (en) | 1969-08-13 | 1971-02-17 | Hoechst Ag | 2- (THIENYL-3'-AMINO) -1,3-DIAZACYCLOALCENES AND THEIR PREPARATION |
| BR6915362D0 (en) * | 1969-08-16 | 1973-01-04 | Hoechst Ag | PROCESS FOR THE PREPARATION OF 2 (TIENIL-3-AMINO) 1,3-DIAZACYCLEALCHENE |
| DE2830279A1 (en) * | 1978-07-10 | 1980-01-31 | Boehringer Sohn Ingelheim | 2-CORNER CLAMP ON N- (2'-CHLOR-4'-METHYL-THIENYL-3 ') - N- (CYCLOPROPYLMETHYL) - AMINO CORNER CLAMP ON-IMIDAZOLINE- (2), THE ACID ADDITION SALTS THAT IT INCLUDES HIS PRODUCTION |
| JP2002521450A (en) * | 1998-07-29 | 2002-07-16 | メルク エンド カムパニー インコーポレーテッド | Integrin receptor antagonist |
| DE19960204A1 (en) * | 1999-12-14 | 2001-06-28 | Aventis Pharma Gmbh | Substituted norlbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
| SI1499311T1 (en) * | 2002-03-29 | 2010-03-31 | Novartis Vaccines & Diagnostic | Substituted benzazoles and use thereof as raf kinase inhibitors |
-
2002
- 2002-06-04 DE DE10224892A patent/DE10224892A1/en not_active Withdrawn
-
2003
- 2003-05-26 MX MXPA04011986A patent/MXPA04011986A/en active IP Right Grant
- 2003-05-26 WO PCT/EP2003/005465 patent/WO2003101984A1/en active IP Right Grant
- 2003-05-26 CN CNB038128462A patent/CN1324024C/en not_active Expired - Fee Related
- 2003-05-26 DK DK03740148T patent/DK1513834T3/en active
- 2003-05-26 OA OA1200400321A patent/OA12827A/en unknown
- 2003-05-26 BR BR0311548-8A patent/BR0311548A/en not_active IP Right Cessation
- 2003-05-26 EP EP03740148A patent/EP1513834B1/en not_active Expired - Lifetime
- 2003-05-26 UA UA20041211000A patent/UA77551C2/en unknown
- 2003-05-26 KR KR1020047019725A patent/KR101087966B1/en not_active IP Right Cessation
- 2003-05-26 ES ES03740148T patent/ES2258722T3/en not_active Expired - Lifetime
- 2003-05-26 JP JP2004509675A patent/JP4511924B2/en not_active Expired - Fee Related
- 2003-05-26 RS YUP-1038/04A patent/RS51141B/en unknown
- 2003-05-26 DE DE50302673T patent/DE50302673D1/en not_active Expired - Lifetime
- 2003-05-26 ME MEP-276/08A patent/MEP27608A/en unknown
- 2003-05-26 AU AU2003273553A patent/AU2003273553B2/en not_active Ceased
- 2003-05-26 PL PL03372589A patent/PL372589A1/en not_active Application Discontinuation
- 2003-05-26 PT PT03740148T patent/PT1513834E/en unknown
- 2003-05-26 RU RU2004138812/04A patent/RU2315766C2/en not_active IP Right Cessation
- 2003-05-26 AT AT03740148T patent/ATE320425T1/en active
- 2003-05-26 CA CA2488242A patent/CA2488242C/en not_active Expired - Fee Related
- 2003-05-30 PE PE2003000531A patent/PE20040534A1/en not_active Application Discontinuation
- 2003-06-02 TW TW092114860A patent/TWI283675B/en not_active IP Right Cessation
- 2003-06-02 AR ARP030101958A patent/AR040239A1/en active IP Right Grant
- 2003-06-03 MY MYPI20032052A patent/MY129832A/en unknown
-
2004
- 2004-11-10 ZA ZA200409095A patent/ZA200409095B/en unknown
- 2004-11-16 MA MA27952A patent/MA27204A1/en unknown
- 2004-11-19 CR CR7577A patent/CR7577A/en unknown
- 2004-12-02 IL IL165519A patent/IL165519A/en not_active IP Right Cessation
- 2004-12-02 EC EC2004005471A patent/ECSP045471A/en unknown
- 2004-12-03 TN TNP2004000240A patent/TNSN04240A1/en unknown
- 2004-12-03 HR HR20041153A patent/HRP20041153A2/en not_active Application Discontinuation
- 2004-12-16 NO NO20045504A patent/NO329351B1/en not_active IP Right Cessation
-
2005
- 2005-09-23 HK HK05108392A patent/HK1076460A1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03005018A (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use. | |
| MXPA03005019A (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use. | |
| ZA200502247B (en) | Selected CGRP antagonists, method for production and use thereof as medicament. | |
| HUS1400056I1 (en) | Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof | |
| HK1076095A1 (en) | Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same | |
| MXPA03001483A (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof. | |
| PL378065A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
| AU2003257465A1 (en) | Substituted diaryl heterocycles, method for the production and use thereof as medicaments | |
| HK1081965A1 (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
| ZA200409381B (en) | Ring-substituted diphenyl azetidones, method for the production thereof, medicaments containing said compounds, and use thereof | |
| HK1076460A1 (en) | Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same | |
| IL162316A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t | |
| MXPA03001510A (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof. | |
| IL150228A0 (en) | Substituted norbornylamino derivatives, method for the production thereof, use thereof as medicament or a diagnostic reagent and medicaments containing said compounds | |
| ZA200601001B (en) | Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicament comprising the same | |
| ZA200407361B (en) | Acyl-3-carboxyphenylurea derivatives, method for production and use thereof. | |
| IL175237A (en) | Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments and medicaments containing the same | |
| IL162562A0 (en) | Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid | |
| HK1073656A1 (en) | Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent | |
| SI1513834T1 (en) | Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same | |
| MXPA03007550A (en) | Caloporoside derivatives, methods for the production thereof and their use. | |
| HK1051853A1 (en) | Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same. | |
| SI1509498T1 (en) | Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same | |
| SI1560826T1 (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
| ZA200410133B (en) | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments. |